Professional Documents
Culture Documents
1. Pada kelainan traktus bilier parameter laboratorium apa saja yang meningkat
Jawab:
The presentation of acute obstruction of the common bile duct by a stone usually
includes biliary pain, similar to the pain of cystic duct obstruction, andif of
sufficient durationis followed by jaundice. Most patients with obstruction have
elevated liver enzymes (alanine aminotransferase [ALT], aspartate aminotransferase
[AST]) in the acute phase of obstruction. In the later course ALT and AST decrease
toward normal even if the obstruction persists, whereas alkaline phosphatase rises,
followed by bilirubin elevation and eventually jaundice.
Oral Cholecystography
Once considered the diagnostic procedure of choice for gallstones, oral
cholecystography has largely been replaced by ultrasonography. It involves oral
administration of a radiopaque compound that is absorbed, excreted by the liver, and
passed into the gallbladder. Stones are noted on a film as filling defects in a
visualized, opacified gallbladder. Oral cholecystography is of no value in patients
with intestinal malabsorption, vomiting, obstructive jaundice, and hepatic failure.
sumber: schwartz
Cholesterol Stones.
Pure cholesterol stones are uncommon and account for <10% of all stones. They
usually occur as single large stones with smooth surfaces. Most other cholesterol
stones contain variable amounts of bile pigments and calcium, but are always >70%
cholesterol by weight. These stones are usually multiple, of variable size, and may be
hard and faceted or irregular, mulberry-shaped, and soft Most cholesterol stones are
radiolucent; <10% are radiopaque
sumber: schwartz
Komposisi:
Ursodeoxycholic acid 250 mg.
Bentuk Sediaan:
Kapsul.
Farmakologi:
Ursodeoxycholic acid adalah asam empedu tersier yang memiliki potensi untuk mengurangi tingkat
kejenuhan asam empedu, sehingga akan menekan pembentukan batu kolesterol dan memperbaiki
gangguan pada aliran asam empedu. Ursodeoxycholic acid menekan sintesis dan sekresi kolesterol
dari hati dan juga menghambat penyerapan kolesterol pada usus. Ursodeoxycholic acid juga memiliki
aktivitas penghambatan kecil pada sintesis dan sekresi asam empedu endogen, tanpa
mempengaruhi sekresi fosfolipid ke dalam empedu.
Indikasi:
Untuk pasien dengan batu empedu radiolusen tanpa kalsifikasi (diameter < 20 mm) sebelum
dilakukannya tindakan cholecystectomy elektif, kecuali pada pasien dengan penyakit sistemik, pasien
lanjut usia, reaksi idiosinkrasi terhadap anestesi umum, atau pasien yang menolak tindakan
pembedahan.
Dosis:
- Dosis umum : 8 10 mg / kg BB / hari dlm 2 3 dosis terbagi. Umumnya dosis 250 mg diberikan
pada pagi dan malam hari.
- Dosis dapat dibagi tidak rata dan dosis lebih besar diberikan sebelum tidur untuk menghalangi
peningkatan konsentrasi kolesterol empedu di malam hari.
Kontraindikasi:
- Batu kolesterol yang mengalami kalsifikasi, batu pigmen empedu yg radiolusen dan radioopak.
- Kolesistitis akut, kolangitis, obstruksi bilier, pankreatitis, fistula gastrointestinal bilier.
- Alergi asam empedu.
- Kehamilan.
- Gangguan fungsi ginjal.
Interaksi Obat:
- Menghambat absorpsi ursodeoxycholic acid: kolestiramin, kolestipol, aluminium hidroksida.
- Penggunaan bersama hormon estrogen dapat mempercepat pembentukan batu empedu.
The aetiology of PCD is unknown and appears to be multifactorial. There are some so far
unknown factors, which can accelerate the colonic transit time significantly and lead to a
significant decrease of faecal consistency after cholecystectomy. These changes in some
cases are strong enough to develop PCD.